Your browser doesn't support javascript.
loading
Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals.
Jost, Stefanie T; Kaldenbach, Marie-Ann; Antonini, Angelo; Martinez-Martin, Pablo; Timmermann, Lars; Odin, Per; Katzenschlager, Regina; Borgohain, Rupam; Fasano, Alfonso; Stocchi, Fabrizio; Hattori, Nobutaka; Kukkle, Prashanth Lingappa; Rodríguez-Violante, Mayela; Falup-Pecurariu, Cristian; Schade, Sebastian; Petry-Schmelzer, Jan Niklas; Metta, Vinod; Weintraub, Daniel; Deuschl, Guenther; Espay, Alberto J; Tan, Eng-King; Bhidayasiri, Roongroj; Fung, Victor S C; Cardoso, Francisco; Trenkwalder, Claudia; Jenner, Peter; Ray Chaudhuri, K; Dafsari, Haidar S.
Afiliação
  • Jost ST; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Kaldenbach MA; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Antonini A; Parkinson and Movement Disorders Unit, Department of Neurosciences (DNS), University of Padua, Padova, Italy.
  • Martinez-Martin P; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain.
  • Timmermann L; Department of Neurology, University Hospital Giessen and Marburg, Marburg, Germany.
  • Odin P; Division of Neurology, Lund University, Lund, Sweden.
  • Katzenschlager R; Department of Neurology, Skåne University Hospital, Lund, Sweden.
  • Borgohain R; Department of Neurology, Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders at Klinik Donaustadt, Vienna, Austria.
  • Fasano A; Department of Neurology, Nizam's Institute of Medical Sciences, Hyderabad, India.
  • Stocchi F; Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital-University Health Network (UHN), Toronto, Ontario, Canada.
  • Hattori N; Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Kukkle PL; Krembil Research Institute, Toronto, Ontario, Canada.
  • Rodríguez-Violante M; Department of Parkinson's Disease & Movement Disorders Rehabilitation, Moriggia-Pelascini Hospital-Gravedona ed Uniti, Como, Italy.
  • Falup-Pecurariu C; University and Institute for Research and Medical Care IRCCS San Raffaele, Rome, Italy.
  • Schade S; Department of Neurology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Petry-Schmelzer JN; Center for Parkinson's Disease and Movement Disorders, Manipal Hospital, Bangalore, India.
  • Metta V; Parkinson's Disease and Movement Disorders Clinic, Bangalore, India.
  • Weintraub D; Insituto Nacional de Neurologia y Neurocirugia, Movement Disorders Clinic, Mexico City, Mexico.
  • Deuschl G; Movement Disorder Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico.
  • Espay AJ; Department of Neurology, Faculty of Medicine, Transilvania University of Brașov, Brașov, Romania.
  • Tan EK; Department of Neurology, County Emergency Clinic Hospital, Brașov, Romania.
  • Bhidayasiri R; Department of Clinical Neurophysiology, University Medical Center Göttingen, Göttingen, Germany.
  • Fung VSC; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Cardoso F; Parkinson Foundation International Centre of Excellence, King's College Hospital, London, United Kingdom.
  • Trenkwalder C; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Jenner P; Departments of Psychiatry and Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ray Chaudhuri K; Parkinson's Disease Research, Education and Clinical Center (PADRECC), Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
  • Dafsari HS; Department of Neurology, University Hospital Schleswig-Holstein (UKSH), Christian-Albrechts-University Kiel, Kiel, Germany.
Mov Disord ; 38(7): 1236-1252, 2023 07.
Article em En | MEDLINE | ID: mdl-37147135
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Revista: Mov Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha